(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GAMIFANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GAMIFANT

ST13

US500000087283834

Class

1, 5

Filing

87283834

Registration

5505933

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

10/29/2023

Trademark type

Word

Nice classes

1, 5

Filing date

12/29/2016

Registration date

07/03/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/03/2018

Last transaction

10/29/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

PLAN-LES-OUATES, GENEVA, CH

Examiner

LEE, JEANIE H

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

SWEDISH ORPHAN BIOVITRUM AG
EMACO SA
NovImmune SA

Representatives

Brendan J. Hughes COOLEY LLP

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biochemicalspolypeptidessuperantigensbiomarkers and antibodies for medical and scientific research; cellscell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes

Class 5

Pharmaceutical and biological preparations to treat immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; pharmaceutical and biological preparations based on polypeptidessuperantigensbiomarkers and antibodies to treat immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune responseall for use in the diagnosispreventionmanagement and treatment of immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; therapeutic and diagnostic agentspreparations and substances for medical purpose for use in therapies for immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; biochemical substancepolypeptidesantibodiesbiomarkers and superantigens for use in diagnoses and therapies for immunologicalinflammatoryoncologicalviralinfectiousneurologicalmusculoskeletalrespiratorydermatological diseasesdisorders and conditions; engineered cell therapiesnamely engineered T cellsimmune cellsantibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medicaldiagnostic and therapeutic purposes

Publications

History of USPTO decisions and trademark events.

38 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/18/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/18/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/18/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/18/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/18/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/18/2023

E815

TEAS SECTION 8 & 15 RECEIVED

08/30/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/03/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/20/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/20/2023

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

04/20/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/20/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/20/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/20/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/20/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/25/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

07/17/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

07/03/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/17/2018

PUBO

PUBLISHED FOR OPPOSITION

04/17/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/28/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/13/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/13/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/12/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/12/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/02/2017

GNRT

NON-FINAL ACTION E-MAILED

11/02/2017

CNRT

NON-FINAL ACTION WRITTEN

11/02/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/12/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/12/2017

ALIE

ASSIGNED TO LIE

10/10/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/27/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/27/2017

GNRT

NON-FINAL ACTION E-MAILED

03/27/2017

CNRT

NON-FINAL ACTION WRITTEN

03/27/2017

DOCK

ASSIGNED TO EXAMINER

03/27/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/10/2017

NWAP

NEW APPLICATION ENTERED

01/02/2017

Continuous trademark protection

Get notified about every new filing that threatens GAMIFANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.